Burn :: Burn Awareness – Forty-Three Percent of All Burns Happen at Home

It is estimated that more than one million burn injuries occur every year and of that, 50 percent could be avoided. Burn Awareness Week, observed the first full week in February each year, is an opportunity to remind parents and children about potential hazards that can lead to burns in the home.

Aging :: No proof that growth hormone therapy makes you live longer

Surveyors of anti-aging elixirs tout human growth hormone as a remedy for all things sagging-from skin to libidos — and claim it can even prevent or reverse aging. But researchers at the Stanford University School of Medicine say there’s no evidence to suggest that this purported fountain of youth has any more effect than a trickle of tap water when it comes to fending off Father Time.

Skin :: Genetically altered cells may help artificial skin fight infection

Cincinnati burn researchers have created genetically modified skin cells that, when added to cultured skin substitutes, may help fight off potentially lethal infections in patients with severe burns. Led by University of Cincinnati scientists, the team found that skin cells that were genetically altered to produce higher levels of a protein known as human beta defensin 4 killed more bacteria than normal skin cells.

Skin Care :: Phototherapy for neonatal jaundice associated with increased risk of skin moles in childhood

Children who received light therapy (phototherapy) for jaundice as infants appear to have an increased risk of developing skin moles in childhood, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals. Some types of moles are risk factors for developing the skin cancer melanoma.

Skin Care :: FDA warns five firms to stop compounding topical anesthetic creams

The Food and Drug Administration (FDA) is warning five firms, Triangle Compounding Pharmacy, University Pharmacy, Custom Scripts Pharmacy, Hal?s Compounding Pharmacy, and New England Compounding Center, to stop compounding and distributing standardized versions of topical anesthetic creams, which are marketed for general distribution rather than responding to the unique medical needs of individual patients.